Arrivent Biopharma (AVBP)'s 30-day implied volatility (IV30) was 57.4% at the close on November 10, 2026, down from 64.0% the day before, against a 52-week range of 33.7% to 256.6%. Its 20-day historical volatility was 86.5%.
Data as of November 10, 2026.